Steinert A F, Noth U, Tuan R S. Concepts in gene therapy for cartilage repair[J]. Injury, 2008, 39(Suppl 1): S97-S113. [2]Steinert A F, Ghivizzani S C, Rethwilm A, et al. Major biological obstacles for persistent cell-based regeneration of articular cartilage[J]. Arthritis Res Ther, 2007, 9(3): 213. [3]Nishimura R, Hata K, Ono K, et al. Regulation of endochondral ossification by transcription factors[J]. Front Biosci (Landmark Ed), 2012, 17: 2657-2666. [4]Cao X, Chen D. The BMP signaling and ？in vivo？ bone formation[J]. Gene, 2005, 357(1): 1-8. [5]Tsumaki N, Yoshikawa H. The role of bone morphogenetic proteins in endochondral bone formation[J]. Cytokine Growth Factor Rev, 2005, 16(3): 279-285. [6]Estrada K D, Wang W, Retting K N, et al. Smad7 regulates terminal maturation of chondrocytes in the growth plate[J]. Dev Biol, 2013, 382(2): 375-384. [7]Liao J, Hu N, Zhou N, et al. Sox9 potentiates BMP2-induced chondrogenic differentiation and inhibits BMP2-induced osteogenic differentiation[J]. PLoS One, 2014, 9(2): e89025. [8]Nishimura R, Hata K, Matsubara T,et al. Regulation of bone and cartilage development by network between BMP signalling and transcription factors[J]. J Biochem, 2012, 151(3): 247-254. [9]Jain A, Kebaish K M, Sponseller P D. Factors associated with use of bone morphogenetic protein during pediatric spinal fusion surgery: an analysis of 4817 patients[J]. J Bone Joint Surg Am, 2013, 95(14): 1265-1270. [10]Iwai T, Murai J, Yoshikawa H, et al. Smad7 inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathways[J]. J Biol Chem, 2008, 283(40): 27154-27164.〖HJ2.2mm〗 [11]Mi M, Jin H, Wang B, et al. Chondrocyte BMP2 signaling plays an essential role in bone fracture healing[J]. Gene, 2013, 512(2): 211-218. [12]Wang M, Shen J, Jin H, et al. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis[J]. Ann N Y Acad Sci, 2011,1240: 61-69. [13]Johansson N Saarialho-Kere U, Airola K,et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development[J]. Dev Dyn, 1997, 208(3): 387-397.
